CNC · available-data snapshot
Centene Corporation (CNC): Available-Data Snapshot
TickerWorth does not publish a DCF fair value for Centene Corporation (CNC); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
Why is there no fair value for CNC?
We do not publish a fair value for Centene Corporation. What we can say from its filings and market data is below.
What is CNC's TickerWorth Score?
Cheap against our estimate — but a weaker business
Compared with Healthcare companies in US
Its strongest point: looks cheap on the numbers. Its weakest: profitability is weak.
our cash-flow model doesn't fit this business, so we won't award our top grade off the remaining lenses
- Value · 98 of 100
Cheaper than 98% of Healthcare companies in US
- Price vs worth · 100 of 100
- Quality · 23 of 100
More profitable than 23% of Healthcare companies in US
- Financial health · 54 of 100
Financially stronger than 54% of Healthcare companies in US
- Growth · 29 of 100
Growing faster than 29% of Healthcare companies in US
- Momentum · 92 of 100
Outperformed 92% of Healthcare companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- $68.09
- Market cap
- $33,
636, 118, 528 - 52-week high
- $71.21
- 52-week low
- $31.63
- Currency
- USD
- Exchange
- NYSE
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
We don't publish a discounted-cash-flow fair value for Centene Corporation (CNC) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
Read the full reasoning
On the numbers we do have, CNC trades at a recent price of $68.09, a market capitalisation of about $33,636,118,528, sitting 92% of the way up its 52-week range ($31.63–$71.21), on the NYSE.
The standard alternative to a DCF is relative valuation — comparing CNC's trading multiples against a sector benchmark. Here that gives Fwd P/E of 12.7× (cheaper than the peer median of 17.5×); P/B of 1.5× (cheaper than the peer median of 7.8×); P/S of 0.2× (cheaper than the peer median of 6.2×); EV/EBITDA of 5.1× (cheaper than the peer median of 18.5×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. CNC shows a price-to-book (P/B) of 1.49 and book value of $45.67 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.
Finally, a price-based read — explicitly not a valuation. CNC is in an up-trend (price above both its 50- and 200-day averages), trading -4.4% from its 52-week high. Over the past year the stock is +94.2%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
CNC vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | CNC | Peer median | Read |
|---|---|---|---|
| Fwd P/E | 12.7× | 17.5× | cheaper than |
| P/B | 1.5× | 7.8× | cheaper than |
| P/S | 0.2× | 6.2× | cheaper than |
| EV/EBITDA | 5.1× | 18.5× | cheaper than |
What does Centene Corporation do?
What does it do?
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. It operates in the Healthcare Plans industry (Healthcare sector), headquartered in United States. The company employs roughly 61,100 people.
How does it make money?
The business turns $174.6B in annual revenue into profit. Out of every $100 of sales, about $4 is left as operating profit (operating margin of 3.8%), after a 11% gross margin on the products/services it sells. After all costs, taxes and interest, -2.8% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks solid: carries modest debt (0.7× equity), can just cover its short-term bills (1.1× current ratio), and is currently lossmaking.
Who at CNC filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| Carson Michael A | Group President, Medicare&Spec | Shares withheld (tax) | $500,240.80 | Form 4 for Carson Michael A (opens sec.gov in a new tab) | |
| Tyler Lauren M | Director | Grant / award | — | Form 4 for Tyler Lauren M (opens sec.gov in a new tab) | |
| TANJI KENNETH | Director | Grant / award | — | Form 4 for TANJI KENNETH (opens sec.gov in a new tab) | |
| Samuels Theodore R. II | Director | Grant / award | — | Form 4 for Samuels Theodore R. II (opens sec.gov in a new tab) | |
| EPPINGER FREDERICK H | Director | Grant / award | — | Form 4 for EPPINGER FREDERICK H (opens sec.gov in a new tab) | |
| COUGHLIN CHRISTOPHER J | Director | Grant / award | — | Form 4 for COUGHLIN CHRISTOPHER J (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.